Paige AI
FDA-cleared AI for prostate cancer pathology
What is Paige AI?
Paige AI is an FDA-cleared artificial intelligence system designed to assist pathologists in analysing prostate cancer tissue samples. The tool helps identify and classify cancerous cells in histopathology images, providing a second opinion to support diagnostic accuracy. It's built specifically for pathology labs and hospitals that handle prostate cancer diagnosis, where precision is critical for patient treatment decisions. The FDA clearance indicates the system has met regulatory standards for safety and effectiveness in this specific medical application.
Key Features
FDA-cleared algorithm
Regulatory approval for clinical use in prostate cancer diagnosis
Histopathology image analysis
Processes microscopy slides to identify cancerous tissue patterns
Diagnostic support
Provides AI-assisted classification to help pathologists make decisions
Integration with lab workflows
Designed to work within existing pathology laboratory processes
Risk assessment
Helps categorise cancer aggressiveness and grade
Pros & Cons
Advantages
- Regulatory approval means it meets clinical safety and accuracy standards
- Free to use, removing cost barriers for pathology labs
- Reduces diagnostic burden on pathologists by providing automated analysis
- Helps ensure consistency in cancer grading across different labs
- Supports better patient outcomes through improved diagnostic accuracy
Limitations
- Limited to prostate cancer pathology; not applicable to other cancer types
- Requires integration into existing lab infrastructure and workflows
- Results should be reviewed by qualified pathologists; AI is a tool, not a replacement
Use Cases
Pathology labs reviewing prostate biopsy samples for cancer diagnosis
Hospital laboratory departments supporting oncology teams
Second opinion analysis on ambiguous or difficult prostate tissue samples
Training and quality assurance in pathology departments
Research institutions studying prostate cancer diagnosis patterns